Challenges in chronic illness management: a qualitative study of Australian pharmacists' perspectives.

Pharmacy World & Science : PWS
Elin C Lehnbom, Jo-anne E Brien

Abstract

To explore pharmacists' views on managing patients with chronic illness; to understand the incentives and barriers they perceive and the solutions they propose to overcome these barriers. Hospital pharmacists, with experience in managing people with chronic illnesses, working in western Sydney, Australia, were interviewed during June and July 2008. A qualitative study involving group and individual interviews using a semi-structured interview guide. Hospital pharmacists identified lack of communication between different healthcare providers and with patients as a contributing factor to lack of continuity of care and this was perceived as a major barrier in managing patients with chronic illnesses. Pharmacists were also concerned about the effects of medication costs, and poor patient knowledge regarding their disease and medications, and the effects on adherence. Suggested solutions included taking a teamwork approach in the management of chronic illness and providing more information to patients to improve adherence. The identified incentives and barriers have provided valuable information on what pharmacists face in managing patients with chronic illness. Most of the solutions suggested by them have been tested and proven uns...Continue Reading

References

Jan 22, 2000·BMJ : British Medical Journal·C PopeN Mays
Jun 15, 2000·Journal of the American Pharmaceutical Association : APhA·L M Schapansky, J A Johnson
Jun 29, 2002·The Medical Journal of Australia·Andrea MantWendy C Rotem
Aug 26, 2004·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Claire AndersonMiriam Armstrong
Dec 13, 2005·Pharmacy World & Science : PWS·Alexander M ClarkMargaret E Reid
Dec 2, 2006·Research in Social & Administrative Pharmacy : RSAP·Sharrel L PintoGayle Kamm
Jul 20, 2007·Journal of Clinical Pharmacy and Therapeutics·A PonniahM Angley
Jan 22, 2008·The Medical Journal of Australia·Jane P Hall, Rosalie C Viney
Apr 22, 2008·The Cochrane Database of Systematic Reviews·R B HaynesX Yao
May 17, 2008·American Journal of Pharmaceutical Education·Jennifer Cerulli, Margaret Malone
May 31, 2008·BMJ : British Medical Journal·Trisha GreenhalghSusan Hinder
Jul 22, 2009·The Medical Journal of Australia·Brett V Silvester, Simon J Carr
Mar 20, 2010·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Robert A Moye
Jun 17, 2010·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Laurann YenTim Usherwood
Dec 8, 2010·Australian Journal of Primary Health·Yun-Hee JeonClive Aspin

❮ Previous
Next ❯

Citations

Sep 17, 2013·Revue D'épidémiologie Et De Santé Publique·S LauvergeonI Peytremann-Bridevaux
Mar 10, 2015·Research in Social & Administrative Pharmacy : RSAP·Sarab M MansoorParisa Aslani
Nov 6, 2012·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Stéphanie LauvergeonIsabelle Peytremann-Bridevaux

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.